These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 34919011)

  • 61. Integrative Data Mining Approach: Case Study with Adverse Outcome Pathway Network Leading to Pulmonary Fibrosis.
    Jeong J; Kim D; Choi J
    Chem Res Toxicol; 2023 Jun; 36(6):838-847. PubMed ID: 37093963
    [TBL] [Abstract][Full Text] [Related]  

  • 62. The adverse outcome pathway concept: A basis for developing regulatory decision-making tools.
    Delrue N; Sachana M; Sakuratani Y; Gourmelon A; Leinala E; Diderich R
    Altern Lab Anim; 2016 Oct; 44(5):417-429. PubMed ID: 27805824
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Adverse outcome pathways: Application to enhance mechanistic understanding of neurotoxicity.
    Bal-Price A; Meek MEB
    Pharmacol Ther; 2017 Nov; 179():84-95. PubMed ID: 28529068
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Application of radiation omics in the development of adverse outcome pathway networks: an example of radiation-induced cardiovascular disease.
    Azimzadeh O; Moertl S; Ramadan R; Baselet B; Laiakis EC; Sebastian S; Beaton D; Hartikainen JM; Kaiser JC; Beheshti A; Salomaa S; Chauhan V; Hamada N
    Int J Radiat Biol; 2022; 98(12):1722-1751. PubMed ID: 35976069
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Toxicogenomics Data for Chemical Safety Assessment and Development of New Approach Methodologies: An Adverse Outcome Pathway-Based Approach.
    Saarimäki LA; Morikka J; Pavel A; Korpilähde S; Del Giudice G; Federico A; Fratello M; Serra A; Greco D
    Adv Sci (Weinh); 2023 Jan; 10(2):e2203984. PubMed ID: 36479815
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Integrated Approaches to Testing and Assessment: OECD Activities on the Development and Use of Adverse Outcome Pathways and Case Studies.
    Sakuratani Y; Horie M; Leinala E
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():20-28. PubMed ID: 29316278
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Chemical-induced liver cancer: an adverse outcome pathway perspective.
    Sanz-Serrano J; Callewaert E; De Boever S; Drees A; Verhoeven A; Vinken M
    Expert Opin Drug Saf; 2024 Apr; 23(4):425-438. PubMed ID: 38430529
    [TBL] [Abstract][Full Text] [Related]  

  • 68. sAOP: linking chemical stressors to adverse outcomes pathway networks.
    Aguayo-Orozco A; Audouze K; Siggaard T; Barouki R; Brunak S; Taboureau O
    Bioinformatics; 2019 Dec; 35(24):5391-5392. PubMed ID: 31329252
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Development of the adverse outcome pathway "alkylation of DNA in male premeiotic germ cells leading to heritable mutations" using the OECD's users' handbook supplement.
    Yauk CL; Lambert IB; Meek ME; Douglas GR; Marchetti F
    Environ Mol Mutagen; 2015 Dec; 56(9):724-50. PubMed ID: 26010389
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Application of Biomarker Tools Using Bivalve Models Toward the Development of Adverse Outcome Pathways for Contaminants of Emerging Concern.
    Khan B; Ho KT; Burgess RM
    Environ Toxicol Chem; 2020 Aug; 39(8):1472-1484. PubMed ID: 32452040
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Building and Applying Quantitative Adverse Outcome Pathway Models for Chemical Hazard and Risk Assessment.
    Perkins EJ; Ashauer R; Burgoon L; Conolly R; Landesmann B; Mackay C; Murphy CA; Pollesch N; Wheeler JR; Zupanic A; Scholz S
    Environ Toxicol Chem; 2019 Sep; 38(9):1850-1865. PubMed ID: 31127958
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Extracting and Benchmarking Emerging Adverse Outcome Pathway Knowledge.
    Pollesch NL; Villeneuve DL; O'Brien JM
    Toxicol Sci; 2019 Apr; 168(2):349-364. PubMed ID: 30715536
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Associating diethylhexyl phthalate to gestational diabetes mellitus via adverse outcome pathways using a network-based approach.
    Zhang T; Wang S; Li L; Zhu A; Wang Q
    Sci Total Environ; 2022 Jun; 824():153932. PubMed ID: 35182638
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Development of an adverse outcome pathway network for nephrotoxicity.
    Barnes DA; Firman JW; Belfield SJ; Cronin MTD; Vinken M; Janssen MJ; Masereeuw R
    Arch Toxicol; 2024 Mar; 98(3):929-942. PubMed ID: 38197913
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Example of Adverse Outcome Pathway Concept Enabling Genome-to-Phenome Discovery in Toxicology.
    Gust KA; Ji Q; Luo X
    Integr Comp Biol; 2020 Aug; 60(2):375-384. PubMed ID: 32516358
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The adverse outcome pathway (AOP) for chemical binding to tubulin in oocytes leading to aneuploid offspring.
    Marchetti F; Massarotti A; Yauk CL; Pacchierotti F; Russo A
    Environ Mol Mutagen; 2016 Mar; 57(2):87-113. PubMed ID: 26581746
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Data-driven derivation of an adverse outcome pathway linking vascular endothelial growth factor receptor (VEGFR), endocrine disruption, and atherosclerosis.
    Ehrlich D; Krishna S; Kleinstreuer N
    ALTEX; 2024 Jul; ():. PubMed ID: 38979646
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Adverse outcome pathway (AOP): α2u-globulin nephropathy and kidney tumors in male rats.
    Goyak KO; Sarang SS; Franzen A; Borghoff SJ; Ryman-Rasmussen JP
    Crit Rev Toxicol; 2022 May; 52(5):345-357. PubMed ID: 35862579
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A toxicity pathway-oriented approach to develop adverse outcome pathway: AHR activation as a case study.
    Jin Y; Feng M; Ma W; Wei Y; Qi G; Luo J; Xu L; Li X; Li C; Wang Y; Li D; Chen J; Zhao Y; Hou Y; Zhao Q; Jiang L; Xie M; Zheng Y; Yu D
    Environ Pollut; 2021 Jan; 268(Pt B):115733. PubMed ID: 33011576
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Putative adverse outcome pathways of the male reproductive toxicity derived from toxicological studies of perfluoroalkyl acids.
    Lu T; Mortimer M; Li F; Li Z; Chen L; Li M; Guo LH
    Sci Total Environ; 2023 May; 873():162439. PubMed ID: 36848992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.